Dhanuka Agritech has signed an agreement with Bayer AG, Germany for the acquisition of the crop protection active ingredients named �Iprovalicarb� and �Triadimenol� along with the trademark Melody for Iprovalicarb. This Agreement signed by Dhanuka is subject to completion of certain closing actions. This acquisition will help Dhanuka to expand its business in India and in overseas markets and with this Dhanuka will make its global presence.Powered by Capital Market - Live News

Net profit of Dhanuka Agritech rose 15.48% to Rs 117.52 crore in the quarter ended September 2024 as against Rs 101.77 crore during the previous quarter ended September 2023. Sales rose 5.88% to Rs 654.28 crore in the quarter ended September 2024 as against Rs 617.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales654.28617.92 6 OPM %24.3922.91 - PBDT169.33146.58 16 PBT156.66136.70 15 NP117.52101.77 15 Powered by Capital Market - Live News

Dhanuka Agritech will hold a meeting of the Board of Directors of the Company on 6 November 2024Powered by Capital Market - Live News

Dhanuka Agritech announced that ICRA has withdrawn the rating of [ICRA]AA (stable) and [ICRA]A1+ assigned for the bank facilities of the Company. The bank facilities of the Company continued to be rated CARE AA; Stable / CARE A1+` by CARE Ratings.Powered by Capital Market - Live News

The Board of Dhanuka Agritech at its meeting held on 02 August 2024 has approved buyback of up to 5,00,000 fully paid up equity shares at a price of Rs 2,000 per equity share for an aggregate amount not exceeding Rs 100 crore. Powered by Capital Market - Live News